Contact Us

Call Us Now

Advanced Thoracic Tumor Clinical Trials in Oklahoma City, OK

We encourage participation in advanced thoracic tumor clinical trials in Oklahoma City, OK aimed at improving cancer outcomes.

Enroll Now

Advanced Thoracic Tumor Clinical Trials

Our Advanced Thoracic Tumors Clinical Trials in Oklahoma City, OK aim to explore new treatment options for patients with metastatic or advanced thoracic tumors. This study focuses on participants with thoracic tumors and tests a new study drug, in combination with other therapies. The goal is to find the safest and most effective dose for patients. By joining this trial, you will be helping researchers better understand how these treatments work and may also benefit from potentially life changing therapies. The trial is open to adult participants and prioritizes your safety and well-being throughout the process.

Consider participating to help advance cancer treatment

*Participation in the Clinical Trial is completely free of cost and is your choice.

*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.

Study Information

Lung Cancer

Study Name	Protocol Number	Sponsor
Advanced Thoracic Tumors	20230167	Amgen

Thoracic Tumors Care Advancement through Clinical Trials

Advanced thoracic tumors develop when cancer spreads beyond the lungs or chest area to other parts of the body, making it more difficult to treat. These tumors can be challenging to manage due to their advanced stage and complexity.

Hightower is dedicated to researching new potential treatment options for patients with advanced thoracic tumors. Our advanced thoracic tumor clinical trials focus on innovative therapies that aim to improve outcomes and provide hope to those facing this tough diagnosis. With a team of experienced specialists, we work closely to ensure that patients receive the highest level of care and access to the latest advancements in thoracic cancer treatment.

*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.

*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.

What to Expect?

If you choose to participate in advanced thoracic tumor clinical trials in Oklahoma City, OK, completing the form above, a member of our study team will contact you to assess your eligibility. They will review the study details with you to determine if you meet the necessary criteria for this potential breast cancer treatment.

If eligible, you will be invited to a screening at a study site. The study doctors will discuss the trial’s duration and your involvement, answering any questions you may have. Once all details are fully explained, participants will be asked to sign an Informed Consent Form, ensuring full transparency.

*All study-related care is provided at no cost, with expert physicians conducting comprehensive physical exams and assessments.*

Age

18 Years to 100 Years

Gender

All

Condition

Advanced Thoracic Tumor

Current Status

Recruiting

Empower Your Lungs: Understanding Advanced Thoracic Tumors

Advanced thoracic tumors refer to cancers in the chest area, including the lungs, esophagus, and trachea, that have progressed to an advanced stage. These tumors can cause serious complications and affect critical functions of the respiratory and cardiovascular systems.

Common Symptoms:

Some common symptoms of advanced thoracic tumors include:

Persistent cough
Shortness of breath
Chest pain
Hoarseness
Unexplained weight loss
Fatigue

Potential Complications:

Some of the complications that may occur in advanced thoracic tumors include

Respiratory failure
Spread of cancer to other organs (metastasis)
Blood clots
Infections like pneumonia
Fluid buildup around the lungs (pleural effusion)

Early detection and treatment are crucial in managing advanced thoracic tumors and improving outcomes for patients.

Frequently Asked Questions

What are the symptoms of thoracic tumors?

Thoracic tumors often present symptoms like persistent cough, chest pain, shortness of breath, hoarseness, and unexplained weight loss. In advanced stages, patients may experience more severe respiratory issues and fatigue. If you notice these symptoms, it’s essential to seek medical advice, as early detection can lead to better outcomes.

How are thoracic tumors diagnosed?

Thoracic tumors are typically diagnosed through imaging tests like X-rays, CT scans, and MRIs. In some cases, a biopsy may be performed to determine if the tumor is cancerous. These diagnostic methods are critical for identifying the tumor’s stage and formulating a treatment plan.

What are the treatment options for thoracic tumors?

Treatment options for thoracic tumors may include surgery, chemotherapy, radiation therapy, or targeted drug therapies. The choice of treatment depends on the type, size, and stage of the tumor. Advanced Thoracic Tumors Clinical Trials may also offer access to innovative therapies.

Are all thoracic tumors cancerous?

No, not all thoracic tumors are cancerous. Some can be benign, but even benign tumors may require treatment due to their location and potential to cause complications. Advanced diagnostic methods help distinguish between benign and malignant tumors.

What happens during advanced thoracic tumors clinical trials?

During Advanced Thoracic Tumors Clinical Trials, participants may receive investigational treatments that are not yet widely available. These trials focus on assessing the safety and efficacy of new therapies for managing advanced thoracic tumors, including new drug combinations or treatment protocols.

Why participate in advanced thoracic tumors clinical trials?

Participating in Advanced Thoracic Tumors Clinical Trials in Oklahoma City, OK, offers patients the opportunity to access cutting-edge treatments that may not be available through standard care. Clinical trials also contribute to medical advancements, potentially benefiting future patients.